|
|
|
Volumn 58, Issue SUPPL. 10, 1997, Pages 45-49
|
|
Dosing the antipsychotic medication olanzapine
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HALOPERIDOL;
OLANZAPINE;
PLACEBO;
AKATHISIA;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DROWSINESS;
DRUG EFFICACY;
EXTRAPYRAMIDAL SYMPTOM;
HUMAN;
HYPERPROLACTINEMIA;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
PSYCHOSIS;
RANDOMIZED CONTROLLED TRIAL;
SCHIZOPHRENIA;
TARDIVE DYSKINESIA;
WEIGHT GAIN;
AKATHISIA, DRUG-INDUCED;
ANTIPSYCHOTIC AGENTS;
BASAL GANGLIA DISEASES;
BENZODIAZEPINES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
HALOPERIDOL;
HUMANS;
MALE;
PIRENZEPINE;
PROLACTIN;
PSYCHIATRIC STATUS RATING SCALES;
RANDOMIZED CONTROLLED TRIALS;
SCHIZOPHRENIA;
SCHIZOPHRENIC PSYCHOLOGY;
|
|
EID: 0030791781
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (163)
|
|
References (5)
|
